RozengurtESinnett-SmithJ.Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci USA1983; 80: 2936–40
3.
RozengurtE.Neuropeptides as cellular growth factors: Role of multiple signalling pathways. Eur J Clin Invest1991; 21: 123–34
4.
WollPJ. Growth factors and lung cancer. Thorax1991; 46: 924–9
5.
CuttittaFCarneyDNMulshineJMoodyTWFedorkoJFischlerA, Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature1985; 316: 823–6
6.
KelleyMJAvisILinnoilaRIRichardsonGSniderRPharesJ, Complete response in a patient with small cell lung cancer (SCLC) treated on a phase II trial using a murine monoclonal antibody (2A11) directed against gastrin releasing peptide. Proc Am Soc Clin Oncol1993; 12: 339
7.
WollPJRozengurtE.Multiple neuropeptides mobilise calcium in small cell lung cancer: Effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem Biophys Res Commun1989; 164: 66–73
8.
DavisTPBurgessHSCrowellSMoodyTWCulling-BerglundALiuRH. β-endorphin and neurotensin stimulate in vitro clonal growth of human SCLC cells. Eur J Pharmacol1989; 161: 283–5
9.
SethiTRozengurtE.Multiple neuropeptides stimulate clonal growth of small cell lung cancer: Effects of bradykinin, vasopressin, cholecystokinin, galanin and neurotensin. Cancer Res1991; 51: 3621–3
10.
SethiTRozengurtE.Galanin stimulates Ca2+ mobilization, inositol phosphate accumulation and clonal growth in small cell lung cancer cells. Cancer Res1991; 51: 1674–9
11.
SethiTRozengurtE.Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res1992; 52: 6031–5
12.
NakanishiYMulshineJLKasprzykPGNataleRBManeckjeeRAvisI, Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell linesin vitro. J Clin Invest1988; 82: 354–9
13.
TateishiMIshidaTMitsudomiTKanekoSSugimachiK.Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res1990; 50: 7077–80
14.
GrazianoSLMazidRNewmanNTatumAOlerAMortimerJA, The use of neuroendocrine immuno-peroxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol1989; 7: 1398–406
15.
WollPJRozengurtE.[Leu13-psi(CH2NH)Leu14] bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells. Biochem Biophys Res Commun1988; 155: 359–65
16.
MahmoudSStaleyJTaylorJ, [Psi13,14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res1991; 51: 1798–802
17.
WollPJRozengurtE. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro. Cancer Res1990; 50: 3968–73
18.
LangdonSSethiTRitchieAMuirMSmythJRozengurtE. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res1992; 52: 4554–7
19.
EngströmUEngströmAErnlundAWestermarkBHeldinC-H. Identification of a peptide antagonist for platelet-derived growth factor. J Biol Chem1992; 267: 16581–7
20.
LottiVJChangRSL. A new potent and selective nonpeptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol1989; 162: 273–80
21.
GarretCCarruetteAFardinVMoussaouiSPeyronelJ-FBlanchardJ-C, Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA1991; 88: 10208–12
22.
MacaulayVMSmithIEEverardMJTealeJDReubiJ-CMillarJL. Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer. Br J Cancer1991; 64: 451–6
